Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye
about
Evaluation of the efficacy of 50% autologous serum eye drops in different ocular surface pathologies.Use of preservative-free hyaluronic acid (Hylabak(®)) for a range of patients with dry eye syndrome: experience in Russia.Hyaluronic acid as an internal wetting agent in model DMAA/TRIS contact lenses.The effects of hyaluronic acid incorporated as a wetting agent on lysozyme denaturation in model contact lens materials.Photocrosslinkable hyaluronic acid as an internal wetting agent in model conventional and silicone hydrogel contact lenses.High molecular weight hyaluronan decreases oxidative DNA damage induced by EDTA in human corneal epithelial cells.Conjunctival goblet cells density and preservative-free tafluprost therapy for glaucoma: an in vivo confocal microscopy and impression cytology study.Sodium hyaluronate eye drops treatment for superficial corneal abrasion caused by mechanical damage: a randomized clinical trial in the People's Republic of ChinaAssessment of dry eye signs and symptoms and ocular tolerance of a preservative-free lacrimal substitute (Hylabak®) versus a preserved lacrimal substitute (Systane®) used for 3 months in patients after LASIK.Efficacy and safety of two new formulations of artificial tears in subjects with dry eye disease: a 3-month, multicenter, active-controlled, randomized trial.Comparison of cytotoxicity and wound healing effect of carboxymethylcellulose and hyaluronic acid on human corneal epithelial cells.Sodium hyaluronate eye drops of different osmolarity for the treatment of dry eye in Sjögren's syndrome patientsGenoprotective effect of hyaluronic acid against benzalkonium chloride-induced DNA damage in human corneal epithelial cells.Performance profile of sodium hyaluronate in patients with lipid tear deficiency: randomised, double-blind, controlled, exploratory study.Effect of 0.3% Hydroxypropyl Methylcellulose/Dextran Versus 0.18% Sodium Hyaluronate in the Treatment of Ocular Surface Disease in Glaucoma Patients: A Randomized, Double-Blind, and Controlled Study.Efficacy of Carboxymethylcellulose and Hyaluronate in Dry Eye Disease: A Systematic Review and Meta-Analysis.Evaluation of a Novel Artificial Tear in the Prevention and Treatment of Dry Eye in an Animal Model.Therapeutic Effects of Sodium Hyaluronate on Ocular Surface Damage Induced by Benzalkonium Chloride Preserved Anti-glaucoma MedicationsComparison of the Anti-Inflammatory Effects of Artificial Tears in a Rat Model of Corneal Scraping.Effectiveness of sodium hyaluronate eye gel in patients with dry eye disease: a multi-centre, open label, uncontrolled study.Preliminary effects of oral uridine on the ocular surface in dry eye patients.Increased concentration of hyaluronan in tears after soaking contact lenses in Biotrue multipurpose solution.Determination of benzalkonium chloride in viscous ophthalmic drops of azithromycin by high-performance liquid chromatography.A Randomized Multicenter Study Comparing 0.1%, 0.15%, and 0.3% Sodium Hyaluronate with 0.05% Cyclosporine in the Treatment of Dry Eye.Ocular drug delivery system: a reference to natural polymers.Towards a dynamic customised therapy for ocular surface dysfunctions.An update on dry eye disease molecular treatment: advances in drug pipelines.Current Approach to Dry Eye Disease.Recommendations for the treatment of Sjögren's syndrome.Trehalose-based eye drops preserve viability and functionality of cultured human corneal epithelial cells during desiccation.The lacrimal gland: development, wound repair and regeneration.The correct diagnosis and therapeutic management of tear dysfunction: recommendations of the P.I.C.A.S.S.O. board.Cytoprotective effect of hyaluronic acid and hydroxypropyl methylcellulose against DNA damage induced by thimerosal in Chang conjunctival cells.Comparison of novel lipid-based eye drops with aqueous eye drops for dry eye: a multicenter, randomized controlled trialEffects of a Hyaluronic Acid/Hydroxypropyl Guar Artificial Tear Solution on Protection, Recovery, and Lubricity in Models of Corneal Epithelium.Comparison of the clinical efficacy of preserved and preservative-free hydroxypropyl methylcellulose-dextran-containing eyedrops.Sodium Hyaluronate in the Treatment of Dry Eye Syndrome: A Systematic Review and Meta-Analysis.Investigating the potential benefits of a new artificial tear formulation combining two polymers.Corneal-protective effects of an artificial tear containing sodium hyaluronate and castor oil on a porcine short-term dry eye model.Sodium hyaluronate (hyaluronic acid) promotes migration of human corneal epithelial cells in vitro.
P2860
Q30432843-3098A464-97B1-495D-A0A3-17961DFBEBB6Q33800691-7D8F646F-2695-44E2-9864-C016C730AF36Q33959003-E754FA0E-04D3-4876-96F5-1389D02DA2BFQ34259156-A19BB19B-2EC3-454F-B1FA-A1DD58AAC804Q34261263-41974B88-4F38-450C-AEFF-A9921C9AA020Q34272980-84131B77-9E33-47EB-AE7E-77BE3614D929Q34678488-4C41FBF2-CF13-417E-B7DF-B833D257DE1BQ35066623-0D45E781-8774-40D9-9646-368CE8754671Q35071714-0D1E236D-9E94-45F3-8ABD-796169462A99Q35507058-0714E914-2F6B-4927-B6A8-3B98271CD72CQ35550022-86CF2F94-1A18-47A3-8FC0-8510A9DE57E3Q35589881-26F51925-6FA4-4BC6-A60F-D3362D4E5722Q35637223-DFFF2E0E-B4AE-4B66-ABFB-42A11087C612Q35762862-E9692760-B2C8-4FB5-8914-4CAC53F8D507Q35865215-81826568-F679-4015-B233-598C8BCC8CA2Q36280601-410E6EB8-F45B-4917-A8A9-0D6BFA7EC2F3Q36362131-E283A447-64FF-4BB0-B03A-593695A95339Q36498525-2C058B17-3867-4AA8-BDA1-875565BBBFDAQ36656777-38C1D39D-475B-4E82-AA72-26FA49CFFDEBQ37280480-088434B5-BD2F-4250-A4C8-5E91EC574D69Q37284729-54B4773E-DCF8-4E3D-8A18-8CD66ED9060DQ37337974-66AC05BB-99B4-4173-A6F6-9888972CEA4DQ37462318-8ED7057C-2ABB-4AA1-8F0C-651E5AD3DC87Q37676992-E5319D34-01B3-4981-B5FB-729C93CD0086Q38019052-28126F96-C76F-4795-9120-69FE700B63BFQ38098900-F2CA5EEC-8442-43A3-97D5-6225029868CBQ38207723-5B3CE1F1-EFA1-4F53-B5D3-A93D6BCE04E5Q38235721-8C644907-84F7-463F-848E-41457A1B38F5Q38584878-2BEF1712-364C-4D87-B710-D13BA4F564F7Q38978082-3D8AA797-C1DF-4CB5-A490-5D24B5322896Q39206326-F0969346-21F4-479E-A5B6-B612E31AA94DQ39233384-01090FF1-E992-41C2-BC99-551E8A297DDCQ39325967-D840D1F7-6887-4E4C-8BE2-986CA6E8F2EAQ39835086-F6B766BB-D864-49C1-B86E-3C47B3A9BBD8Q41056597-377F8867-1725-46D9-A1F0-0631568E9457Q41231339-9981583E-4DB0-48E5-B69B-5608B54F4909Q41489266-9523A5F0-54E8-4898-8C6B-F07D8D147EE1Q41817907-D39B1D33-4D07-4E8E-936E-8EE1B2CB6D38Q42459799-A0D2B351-8772-4751-9A02-4D9408649FCAQ43007758-6D60B36C-A8F7-45A5-B3DD-C1D2364932C9
P2860
Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Long term treatment with sodiu ...... amage in patients with dry eye
@ast
Long term treatment with sodiu ...... amage in patients with dry eye
@en
type
label
Long term treatment with sodiu ...... amage in patients with dry eye
@ast
Long term treatment with sodiu ...... amage in patients with dry eye
@en
prefLabel
Long term treatment with sodiu ...... amage in patients with dry eye
@ast
Long term treatment with sodiu ...... amage in patients with dry eye
@en
P2093
P2860
P356
P1476
Long term treatment with sodiu ...... amage in patients with dry eye
@en
P2093
Antonio Micali
Giovanni Milazzo
Marcello Santocono
Pasquale Aragona
Vincenzo Papa
P2860
P304
P356
10.1136/BJO.86.2.181
P407
P577
2002-02-01T00:00:00Z